Re: Roberti R, Iannone LF, Palleria C, et al. Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy. Curr Med Res Opin. 2020. DOI:10.1080/03007995.2020.1786681.

Published on Aug 5, 2020in Current Medical Research and Opinion2.271
· DOI :10.1080/03007995.2020.1799775
Robyn Laube4
Estimated H-index: 4
(Macquarie University),
Christian P. Selinger25
Estimated H-index: 25
(University of Leeds)
📖 Papers frequently viewed together
10 Citations
2 Citations
Introduction. Inflammatory bowel diseases (IBDs) are a public health issue with over 3.5 million patients in Europe, but the advent of several biologic agents has completely changed their managemen...
18 CitationsSource
#1Pepijn W. A. Thomas (Radboud University Nijmegen)H-Index: 1
#2Rachel WestH-Index: 6
Last. Frank Hoentjen (Radboud University Nijmegen)H-Index: 16
view all 8 authors...
1 CitationsSource
#1Magali LemaitreH-Index: 12
#2Julien Kirchgesner (University of Paris)H-Index: 13
Last. Rosemary Dray-SpiraH-Index: 30
view all 7 authors...
Importance An increased risk of lymphoma has been reported among patients receiving thiopurines for inflammatory bowel disease (IBD). The risk of lymphoma associated with anti–tumor necrosis factor (TNF) agents either alone or in combination with thiopurines is uncertain. Objective To assess the risk of lymphoma associated with thiopurines and anti-TNF agents, used alone or in combination, for the management of IBD. Design, Setting, and Participants Nationwide cohort study based on French Nation...
244 CitationsSource
#1David Fiorentino (Stanford University)H-Index: 59
#2Vincent T. Ho (UBC: University of British Columbia)H-Index: 96
Last. Richard G. Langley (Dal: Dalhousie University)H-Index: 72
view all 11 authors...
Background The effect of systemic therapy on malignancy risk among patients with psoriasis is not fully understood. Objective Evaluate the impact of systemic treatment on malignancy risk among patients with psoriasis in the Psoriasis Longitudinal Assessment and Registry (PSOLAR). Methods Nested case-control analyses were performed among patients with no history of malignancy. Cases were defined as first malignancy (other than nonmelanoma skin cancer) in the Psoriasis Longitudinal Assessment and ...
78 CitationsSource
#1Robert E. Kalb (UB: University at Buffalo)H-Index: 22
#2David Fiorentino (Stanford University)H-Index: 59
Last. Craig L. Leonardi (SLU: Saint Louis University)H-Index: 63
view all 13 authors...
Importance The efficacy of treatment for psoriasis must be balanced against potential adverse events. Objective To determine the effect of treatment on the risk of serious infections in patients with psoriasis. Design, Setting, and Participants A multicenter, longitudinal, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR]) at dermatology centers. Participants were adult patients with psoriasis who were receiving or were eligible to receive conventional systemic or b...
224 CitationsSource
#1Derrick J. Stobaugh (NorthShore University HealthSystem)H-Index: 12
#2Parakkal Deepak (NorthShore University HealthSystem)
Last. Eli D. Ehrenpreis (NorthShore University HealthSystem)H-Index: 28
view all 3 authors...
Background Some studies have purported to link isotretinoin prescribed for acne with the development of inflammatory bowel disease (IBD). Objective We sought to identify existence of disproportionate attorney-initiated reporting of isotretinoin-associated IBD in the Food and Drug Administration Adverse Event Reporting System (FAERS). Methods A total of 3,338,835 cases (2003-2011) were downloaded from the FAERS. These were queried for IBD cases reported with isotretinoin for a usage indication of...
22 CitationsSource
Cited By0